Comparative study of somatostatin-human serum albumin fusion proteins and natural somatostatin on receptor binding, internalization and activation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Peng, Ying ^a   Deng, Lili ^a   Ding, Yuedi ^a   Chen, Quancheng ^a   Wu, Yu ^a   Yang, Meilin ^a,b   Wang, Yaping ^b   Fu, Qiang ^a  

^a JIANGSU INSTITUTE OF NUCLEAR MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SERUM ALBUMIN SOMATOSTATIN FUSION PROTEIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; RECEPTOR BINDING; SEQUENCE ANALYSIS;

CELL LINE; CYCLIC AMP; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; KINETICS; LIGANDS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, SOMATOSTATIN; RECOMBINANT FUSION PROTEINS; SERUM ALBUMIN; SOMATOSTATIN;

EID: 84896106212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089932     Document Type: Article

References (36)

1. Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20: 157-198.
2. Barnett P (2003) Somatostatin and somatostatin receptor physiology. Endocrine 20: 255-264.
3. Jacobs S, Schulz S (2008) Intracellular trafficking of somatostatin receptors. Mol Cell Endocrinol 286: 58-62. (Pubitemid 351680240)
4. Colucci R, Blandizzi C, Ghisu N, Florio T, Del Tacca M (2008) Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation. Br J Pharmacol 155: 198-209.
5. Annunziata M, Luque RM, Duran-Prado M, Baragli A, Grande C, et al. (2012) Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility. Hum Reprod 27: 2117-2129.
6. Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, et al. (1979) Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 48: 50-53. (Pubitemid 9101608)
7. Tulipano G, Schulz S (2007) Novel insights in somatostatin receptor physiology. Eur J Endocrinol 156 Suppl 1: S3-11.
8. Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S (2009) Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab 94: 654-661.
9. Muller D, Karle A, Meissburger B, Hofig I, Stork R, et al. (2007) Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin. J Biol Chem 282: 12650-12660. (Pubitemid 47100581)
10. Czajkowsky DM, Hu J, Shao Z, Pleass RJ (2012) Fc-fusion proteins: new developments and future perspectives. EMBO Mol Med 4: 1015-1028.
11. Halpern W RT, Agostini H, Baker K, Stolow D, Gu ML, et al. (2002) Albugranin, a recombinant human granulocyte colony stimulating factor (GCSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys. Pharm Res 19: 1720-1729. (Pubitemid 35305525)
12. Osborn BL, Sekut L, Corcoran M, Poortman C, Sturm B, et al. (2002) Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys. Eur J Pharmacol 456: 149-158. (Pubitemid 35351748)
13. Duttaroy A KP, Osborn BL, Schneider H, Pickeral OK, Chen C, et al. (2005) Development of a long-acting insulin analog using albumin fusion technology. Diabetes 54: 251-258. (Pubitemid 40105120)
14. Subramanian GM, Fiscella M, Lamouse-Smith A, Zeuzem S, McHutchison JG (2007) Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C. Nat Biotechnol 25: 1411-1419. (Pubitemid 350233139)
15. Zhao J, Si Y, Cheng M, Yang Y, Niu Y, et al. (2013) Albumin Fusion of Interleukin-28B: Production and Characterization of Its Biological Activities and Protein Stability. PLoS One 8: e64301.
16. Sung C NB, LaFleur DW, Blatter E, Corcoran M, Olsen HS, et al. (2003) An IFN-beta-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates. J Interferon Cytokine Res 23: 25-36. (Pubitemid 36308059)
17. Ding Y, Fan J, Li W, Yang R, Peng Y, et al. (2013) The effect of albumin fusion patterns on the production and bioactivity of the somatostatin-14 fusion protein in Pichia pastoris. Appl Biochem Biotechnol 170: 1637-1648.
18. Greenwood FC, Hunter WM, Glover JS (1963) The Preparation of I-131-Labelled Human Growth Hormone of High Specific Radioactivity. Biochem J 89: 114-123.
19. Roca B, Fernandez-Valencia R, Arilla E (1988) Effects of fasting and refeeding on somatostatin concentration and binding to cytosol from rabbit gastric mucosa. Gut 29: 642-646.
20. Dickey DM, Burnett JC, Jr., Potter LR (2008) Novel bifunctional natriuretic peptides as potential therapeutics. J Biol Chem 283: 35003-35009.
21. Lewis I, Bauer W, Albert R, Chandramouli N, Pless J, et al. (2003) A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J Med Chem 46: 2334-2344. (Pubitemid 36637918)
22. Csaba Z, Peineau S, Dournaud P (2012) Molecular mechanisms of somatostatin receptor trafficking. J Mol Endocrinol 48: R1-12.
23. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V, et al. (2004) Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279: 21374-21382. (Pubitemid 38656546)
24. Florio T (2008) Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases. Mol Cell Endocrinol 286: 40-48.
25. Patel YC GM, Warszynska A, Panetta R, Srikant CB (1994) All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198: 605-612. (Pubitemid 24178411)
26. Osborn BL, Olsen HS, Nardelli B, Murray JH, Zhou JX, et al. (2002) Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys. J Pharmacol Exp Ther 303: 540-548. (Pubitemid 35231224)
27. Melder RJ, Osborn BL, Riccobene T, Kanakaraj P, Wei P, et al. (2005) Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. Cancer Immunol Immunother 54: 535-547.
28. Reubi JC (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24: 389-427.
29. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W (2004) Regulation and function of somatostatin receptors. J Neurochem 89: 1057-1091. (Pubitemid 38720193)
30. Sharma K PY, Srikant CB (1996) Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10: 1688-1696.
31. Liu Q, Bee MS, Schonbrunn A (2009) Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation. Mol Pharmacol 76: 68-80.
32. Nagel F, Doll C, Poll F, Kliewer A, Schroder H, et al. (2011) Structural determinants of agonist-selective signaling at the sst (2A) somatostatin receptor. Mol Endocrinol 25: 859-866.
33. DeFea KA (2011) Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal 23: 621-629.
34. Barone R, Van Der Smissen P, Devuyst O, Beaujean V, Pauwels S, et al. (2005) Endocytosis of the somatostatin analogue, octreotide, by the proximal tubule-derived opossum kidney (OK) cell line. Kidney Int 67: 969-976. (Pubitemid 41623320)
35. Kariya Y, Honma M, Aoki S, Chiba A, Suzuki H (2009) Vps33a mediates RANKL storage in secretory lysosomes in osteoblastic cells. J Bone Miner Res 24: 1741-1752.
36. Kariya Y, Honma M, Hanamura A, Aoki S, Ninomiya T, et al. (2011) Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells. J Bone Miner Res 26: 689-703.